about
Leukoencephalopathy due to oral methotrexateA New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish PopulationOutcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance ProgramAn acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease.A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients.Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification SystemLiver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the LiteratureOveruse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital.Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain.Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.Hepatotoxicity induced by acute and chronic paracetamol overdose in children: Where do we stand?Hepatotoxicity induced by acute and chronic paracetamol overdose in adults. Where do we stand?A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia.Non-Chemotherapy-Induced Agranulocytosis Detected by a Prospective Pharmacovigilance Program in a Tertiary Hospital.Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy.Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department.Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram.Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers.Acute complications and outcomes of acute head injury in adult patients with haemophilia.[Valproate-meropenem co-administration, an example of information shortcomings in relevant drug interactions].CYP2C9 polymorphism in five autochthonous population of the same geographic area (Spanish Pyrenees).Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant.A preliminary model to avoid the overestimation of sample size in bioequivalence studies.Influence of two variants of CYP450 oxidoreductase on the stable dose of acenocoumarol in a Spanish population.Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers.Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.Nonchemotherapy drug-induced agranulocytosis in children detected by a prospective pharmacovigilance program.Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals.The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome.Invasive aspergillosis in a paediatric allogeneic stem cell transplantation recipient owing to a susceptible Aspergillus fumigatus: Treatment failure with high doses of voriconazole and influence of CYP2C19 polymorphisms.Rifampin-related acute renal failure, thrombocytopenia, and leukocytoclastic vasculitisVancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signalsSymptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: results from a retrospective cohort studySevere Hyponatremia Is Often Drug Induced: 10-Year Results of a Prospective Pharmacovigilance ProgramEffect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy SubjectsA cohort of patients with COVID-19 in a major teaching hospital in EuropeStrategy to effectively and efficiently implement voriconazole pharmacogenetics in clinical practiceA randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial
P50
Q28299271-E27C18F1-1DA7-427D-9752-3915C3187451Q28550740-B17B1643-3406-45D7-A92D-A05DB8BC13A3Q28551527-05A0BD0D-0C5C-4008-8C3A-A0AFF52A6AA6Q30558676-2F3E12E6-FC2D-46A9-B2A3-98A8DE251A67Q33386953-8CDE121F-9B92-49DB-AD6F-B7DA9DF5D65CQ34381329-0DDDED7E-97B2-4D6A-BA68-79480995CC07Q35061587-9BE5A6BD-740F-44C1-9AA4-E60B6C5948A1Q37798281-2ECBC447-29A7-4C8A-9536-307825BCFFAFQ38515079-5F484A3E-3F85-4AB3-BE25-A44E4774FD91Q39382537-39689D42-A2C5-4B93-B04C-1E5245C09926Q39560375-753150E7-FA7E-41EF-B3E4-9A6949D4FA23Q40927871-3E9715C9-3CD5-4243-B900-E0339FD2C6F3Q41547007-5A39C517-1766-446F-BE02-DCE885DC6ADAQ41716811-3D4957BB-6253-457E-8065-306B707F0615Q42394160-F9ED222F-62EE-4CE1-B47E-38E9CEE07146Q42910896-F0ED83B9-2D0F-4353-9C53-CA058C6CBA01Q42924723-77CBDB0A-88D5-4E8B-A5FB-A29175178736Q43258734-96877533-A5BC-45E1-BCF2-BC01D18E9F15Q43623861-E4537362-5B3A-49E7-A6EB-B83676152433Q45857982-4E7D62AE-AE68-4C4B-8E73-F488E79A4A8AQ45990433-092979C4-1926-4D38-B047-4B7458B59703Q46245767-F54E010D-875B-473F-8082-09285747506FQ47242677-307CCEB0-996A-402F-B0B0-004E0B06F2F6Q47253002-1EEB3864-87D0-490A-BAA3-8CC5A9234C90Q47812050-C13CC116-2354-4695-8B13-B9E48895AEE3Q47849242-EB54F0CB-7CBA-4D40-9BEE-BF78BCB57B37Q47998134-27B2AF6D-C133-4A22-9604-254A1710E241Q48585125-DFC897B0-A59D-4102-932A-F959170E841FQ50222018-5A7C3876-5AD3-4845-8837-2ED3E2ACDDBFQ51335534-ADC2C4DB-4C0F-4FCD-9601-4FC4D77F5336Q53801531-2350AC3F-8291-434D-9618-79D5511CA0D8Q54622280-1E381D5F-2A8B-4352-B195-2D6EBA1797AEQ81088252-2409C792-AD74-4D7F-BD46-F1F046AC0DE6Q86768898-68F848B3-8692-4A66-BD90-4020C2B6EA51Q87679777-750C3C3B-2BB1-409F-BDB6-DA22B8940C56Q93076175-66C7F6BD-3994-49B1-80AA-DCF05B623F43Q94949103-B25360BF-04B6-4792-9FE7-FB10368B63DBQ95625044-D4CD104D-FF90-41F2-A4D3-78FD84DA1EECQ96120994-5799FCFE-E433-4742-967C-3E5C63173464Q96128882-F3250705-885B-49A0-A8FD-8FB25887ADA3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alberto M Borobia
@ast
Alberto M Borobia
@en
Alberto M Borobia
@es
Alberto M Borobia
@nl
Alberto M Borobia
@sl
type
label
Alberto M Borobia
@ast
Alberto M Borobia
@en
Alberto M Borobia
@es
Alberto M Borobia
@nl
Alberto M Borobia
@sl
prefLabel
Alberto M Borobia
@ast
Alberto M Borobia
@en
Alberto M Borobia
@es
Alberto M Borobia
@nl
Alberto M Borobia
@sl
P106
P21
P31
P496
0000-0002-8584-3263